The Disruptive Innovations to Advance Clinical Trials (DPharm) event is the definitive conference committed to transforming the clinical trial enterprise with bold ideas through an original interactive format. The entire program is dedicated to presenting disruptive ideas to greatly enhance the industry’s ability to achieve clinical operational excellence. New York (PRWEB) May 22, 2013 [...]
Setting new standards in information exchange for the pharmaceutical and biotech industry
Conference Forum News
-
February 4, 2013
-
Finally Chief Medical Officers Have Their Own Summit
-
January 16, 2013
-
Monday’s Medicaid Announcement from the CMS
The Centers for Medicare & Medicaid Services published a rule Monday detailing how states should coordinate certain elements of health exchanges and Medicaid. The New York Times: States Will Be Given Extra Time To Set Up Exchanges Under the law, the secretary of health and human services was supposed to determine “on or before Jan. [...]
-
January 16, 2013
-
Blog Posting from Audrey Erbes about New Paradigms 2013
A blog posting regarding the recent New Paradigms to Fund Life Science Innovation conference. Jan 7-9th, 2013 in the Marines Memorial Club & Hotel, San Francisco. Observations: JP Morgan Healthcare Week from Audrey Erbes JP Morgan’s Healthcare Conference is no longer the sole life science event of value in San Francisco as in earlier years. [...]
-
January 4, 2013
-
Blog Posting from Audrey Erbes for New Paradigms 2013
A blog posting regarding the upcoming New Paradigms to Fund Biotech conference. Jan 7-9th, 2013 in the Marines Memorial Club & Hotel, San Francisco. Hi, As promised I’ve collected all the events for the first quarter of 2013 so you can carry out your New Year’s resolution to attend more industry programs to increase your [...]
-
December 11, 2012
-
NAMD Director Points To CMS’ Balancing Act In Medicaid Expansion Policy
A Blog posting from our Media Partner, InsideHealthPolicy.com, visit here for a free trial. As long as the Obama administration views states’ assertions that they will not expand Medicaid as saber rattling — similar to certain states’ negative reaction to stimulus funds that were ultimately accepted — the administration has no reason to allow for a partial expansion [...]
-
December 11, 2012
-
NGA Chair Tells Obama Medicaid Cuts Eyed In Fiscal Debate Put Expansion In Jeopardy
A Blog posting from our Media Partner, InsideHealthPolicy.com, visit here for a free trial. National Governors Association Chair Jack Markell (D-DE) says he made it clear in a Tuesday morning meeting with President Obama on the “fiscal cliff” that Medicaid funding available to states under current law needs to remain in place for states to go [...]
-
December 5, 2012
-
Medicaid Rebate Summit Additional Highlights Announced – Early Bird Ends in 3 Days
New York, NY: The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, announced the latest highlights and additions to the Medicaid Rebate Summit on February 14-15, 2013 in Washington, DC. The Summit opens with Alice Valder Curran of Hogan Lovells on the anticipation of the Final Rule and is followed by an enforcement panel of US Attorney Offices. Highlights: The [...]
-
December 4, 2012
-
A New Medicaid Rebate Summit Announced for Early 2013
The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, is presenting a Medicaid Rebate Summit on February 14-15, 2013 in Washington, DC. The Summit opens with Alice Valder Curran of Hogan Lovells on the anticipation of the Final Rule and is followed by an enforcement panel of US Attorney Offices. The Summit features Health Care Association insights on health care [...]
-
November 27, 2012
-
Our Keynote Dr Langer recognized in NYTs for his Innovation
Hatching Ideas, and Companies, by the Dozens at M.I.T. How do you take particles in a test tube, or components in a tiny chip, and turn them into a $100 million company? Dr. Robert Langer, 64, knows how. Since the 1980s, his Langer Lab at the Massachusetts Institute of Technology has spun out companies whose products treat cancer, diabetes, [...]
-
November 2, 2012
-
A Peak at New Paradigms 2012
A Presentation on an Investors Perspective on Changing Paradigms in Outsourcing This Presentation was delivered by Liz Stoner, MPM Capital, at New Paradigms to Fund Biotech 2012, San Francisco, CA.
-
October 31, 2012
-
New Paradigms to Fund Biotech Conference Announces Keynotes & Event Highlights
New York, NY: The Conference Forum announced today that Dennis Purcell, Senior Managing Partner of Aisling Capital, will host a series of interviews with some of the top, unique life science deals of 2012 on January 8th, 2013 at the 3rd Annual New Paradigms event in San Francisco. Mr Purcell will be interviewing some of [...]
-
October 18, 2012
-
A Peak at New Paradigms 2012
A Presentation on Pharmaceutical Pricing. This Presentation was delivered by Kent Rogers at New Paradigms to Fund Biotech 2012, San Francisco, CA.
-
October 11, 2012
-
Disruptive Innovation in Pharma – Time to get on board!
Thomas Krohn, Director, Eli Lillys Clinical Open Innovations thoughts on Dpharm 2012. Is pharma willing to disrupt itself? What does disruption look like in pharma? If a change is good for everyone, is it really disruptive? These and other questions were explored during the 2 day Disruptive Innovations to Advance Clinical Trials Conference in Boston last month. [...]
-
October 10, 2012
-
The 2nd Biggest Secret to Innovation
Part two of Rob Wright, Chief Editor of Life Science Leaders, blog. Jon Platt, healthcare sector leader for ?WhatIf! Innovation, conducted a presentation at the Conference Forum’s (www.conferenceforum.org) 2nd Annual Disruptive Innovation to Advance Clinical Trials for Pharma, Biologics & Devices conference in Boston. He provided the two biggest secrets to innovation – the first [...]
-
October 4, 2012
-
Disruptive Innovations to Advance Clinical Trials: Thoughts & Themes
A blog posting from one of our 2012 Dpharm attendees: Rahlyn Gossen from Rebar Interactive. If you are often frustrated by the pace of progress in clinical trials,there’s hope. Or at least that’s my feeling after attending the 2nd annual Disruptive Innovations to Advance Clinical Trials conference in Boston. It was a truly refreshing experience. And given [...]
-
October 3, 2012
-
The 2 Biggest Secrets Of Innovation
A blog posting about our 2012 Dpharm program from media partner Rob Wright, Chief Editor of Life Science Leader At this year’s 2nd Annual Disruptive Innovation to Advance Clinical Trials for Pharma, Biologics & Devices conference in Boston, I had the opportunity to sit through a presentation by Jon Platt, healthcare sector leader for ?WhatIf! [...]
-
September 24, 2012
-
Attending Companies at PODD 2012
An update on some of the companies in attendance on October 1-2nd 2012! Ratio Drug Delivery, Allergan, Catalent Pharma Solutions, MIT, Thomas, McNerney & Partners, Astrazeneca, Hovione, Momenta Pharmaceuticals, Pfizer, Inc., Eli Lilly, MannKind Corp, University of Nebraska Medical Center, Xeris Pharma, Vertex Pharmaceuticals, Amgen, PhaseBio Pharmaceuticals Inc., FluGen Inc., Aptalis, Kala Pharmaceuticals/ Polaris Venture [...]
-
September 21, 2012
-
Pictures from New Paradigms 2012
Here are some pictures from the 2012 New Paradigms to Fund and Move Drug Development Conference held on January 11th – 12th, 2012, in the Marines Memorial Club & Hotel, San Francisco.
-
September 20, 2012
-
Rob Wright, Editor, Clinical Leader, talks about Disruptive Ideas on Accelerating Drug Discovery at Disruptive Innovations 2012
This year’s 2nd Annual Disruptive Innovation to Advance Clinical Trials for Pharma, Biologics & Devices conference was held September 13 to 14, in Boston. Having doubled in the number of attendees from last year’s event, it is fairly obvious that the Conference Forum’s executive director, Valerie Bowling, has landed on a topic which resonates loudly with [...]
-
September 20, 2012
-
Jeri Burtchell, Gilenya & Me, gives her impressions of Disruptive Innovations 2012
THURSDAY, SEPTEMBER 20, 2012 My Impressions of the Disruptive Innovations Conference in Boston – Part 3: The Interview If you are just tuning in, you can read parts 1 and 2 of My Impressions of the Disruptive Innovations Conference here: Part 1: http://gilenya.blogspot.com/2012/09/my-impressions-of-disruptive.html Part 2: http://gilenya.blogspot.com/2012/09/my-impressions-of-disruptive_19.html The evening of Day 1 of the event found me networking [...]
-
September 19, 2012
-
Conference Takeaways: Executing Global Clinical Trials and Disruptive Innovations – BBK Worldwide
As the BBK Worldwide team returns from the Executing Global Clinical Trials and Disruptive Innovations Conference in Boston, we reflect on our major takeaways from the event: Matt Kibby It was obvious that there are tremendous synergies between the Disruptive Innovations conference and the Global Clinical Trials conference. At the GCT Conference, an overriding notion [...]
-
September 17, 2012
-
Themes and Thoughts from the Disruptive Innovations Conference by Brendan Kelleher, karmadata
Sean and I recently attended the 2nd Annual Disruptive Innovations to Advance Clinical Trials for Pharma, Biologics, & Devices (DPharm) in Boston. We had a really great time and learned a ton. Here are a few themes that really stood out for me: An increasing momentum for collaboration among pharma: Tom Krohn of Eli Lilly [...]
-
September 12, 2012
-
Craig Lipset, Head of Clinical Innovation at Pfizer, asks, Can We Bring Disruptive Innovation to Clinical Trials?
Later this week I am co-chairing a conference on this topic along with colleagues from Janssen and Novartis. The program will include presentations from pharmaceutical companies, technology companies and others looking to impact this space. Holding a conference on innovation in the conduct clinical trials makes an assumption — that we are actually able to innovate in [...]
-
September 11, 2012
-
Tom Krohn, Director, Lilly Clinical Open Innovation shares his thoughts on the opening of the Disruptive Innovations to Advance Clinical Trials event.
“We need to reinvent invention.” We often hear – including from us on the COI Team – that the drug development model needs to be transformed. How about disrupted? And what does it mean to disrupt the current model? What examples of innovation have been tried and are in the works to disrupt clinical trials and advance [...]
-
September 6, 2012
-
Less than one week to Dpharm 2012! Two New Speakers Announced
Two new speakers have joined the distinguished speaking faculty for the 2nd Annual Disruptive Innovations to Advance Clinical Trials Conference. Penny Mohr, Vice President, Program Development, Pragmatic Studies and Applied Solutions Group, Center for Medical Technology Policy, and Richard Murray, MD, Vice President, Global Center for Scientific Affairs, Merck, both of who will be speaking [...]
-
August 16, 2012
-
Clinical Trials Have Gone Global – Are You Up to Speed?
A Blog post from our Media Partner PharmaVoice Clinical studies are becoming more complex, and are reaching across the globe at a progressively more rapid rate. Sponsors are seeking increased access to patients and investigators, better R & D solutions, and improved efficiencies. Navigating these waters can be treacherous. For most, there are more questions [...]
-
August 14, 2012
-
Four Weeks Left to Register for Dpharm 2012!
Please note, the official conference venue is sold out of sleeping rooms. Please refer to our website for alternative nearby hotels. Out of the Box Registration Options: Partial and Full Scholarships available for early stage biotechs Group Discounts for three or more from the same company, 15% Off $125 Special rate for American Idol Technology [...]
-
August 9, 2012
-
Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
New York, NY — Pharmaceutical and biotech companies are preparing to hear more than 25 presentations, ranging from key behaviors that drive innovation to applying disruptive approaches to achieve pragmatic clinical trials, at the 2nd Annual Disruptive Innovations to Advance Clinical Trials (DPharm) conference. The event is scheduled for September 13-14, 2012 at the Fairmont [...]
-
August 9, 2012
-
A Peak at DPharm 2011
NEED CODE FOR SLIDE A Presentation on Challenges and Opportunities in Clinical Development. This Presentation was delivered by Greg Simon at Dpharm: Disruptive Innovations to Advance Clinical Trials for Pharma, Biologics & Devices 2012. For the 2012 Program Agenda and info please visit http://www.dpharmconference.com/
-
July 27, 2012
-
Globalization – Ethical & Business Considerations in Clinical Research
The ACRO publishes a white paper on Global Clinical Trials. This report analyzes the current state of global clinical research and the role that biopharmaceutical companies and their clinical research organization (CRO) partners play in ensuring that the dual goals of trial safety and quality are met. With the changing landscape for CROs, the report [...]
-
July 27, 2012
-
Coming up on DPharm 2012!
Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly just joined the Disruptive Innovations speaking faculty where he will provide an opening address on: Disruptive Innovation: Moving Beyond the Talk A case for action to move beyond incremental improvement Concrete opportunities for disruptive innovation in clinical development Are you on board? The tide is rising.
-
July 26, 2012
-
Disruptive Innovations 2012 at a Glance!
Disruptive Innovations 2012 at a Glance! At the Disruptive Innovations to Advance Clinical Trials 2nd annual event, you will meet industry leaders determined to reinvent clinical trials. This is an outcomes-focused program with over 30 examples of bold innovative strategies and the application of technology for real changes in clinical trial advancements. Taking place in Boston, MA on September 13-14, the [...]
-
July 16, 2012
-
Another Peak at PODD 2011
A Presentation on Transforming a New Drug or Technology into a Marketed Product. This Presentation was delivered by Mark J. Kontny, PhD, of Patheon Inc. during the 2011 PODD program.
-
July 13, 2012
-
Combating Drug Resistance
Drug resistance is a growing problem in modern medicine. The issue of drug resistance encompasses resistance of bacteria, viruses, parasites and other organisms to antibacterial agents and other drug treatments. This article examines the emergence of multidrug resistant pathogens and introduces a few of the methods available to address the issue – including some new [...]
-
July 3, 2012
-
Drug Delivery Technologies Show Promise of Improving Clinical Outcomes for Patients at PODD
New York, NY — In an effort to remove barriers and embrace collaborations to get therapeutics to patients faster, pharmaceutical and biotech companies will listen to more than 25 drug delivery technology presentations, ranging from novel delivery devices to formulation technologies at the 2nd Annual PODD: Partnership Opportunities in Drug Delivery conference, October 1-2, 2012, [...]
-
July 3, 2012
-
A Peak at PODD 2011
A Presentation on Practical Guidance to Conveying the Value in your Drug Delivery. This Presentation was delivered by Fernando Salles, PhD, CLP, of Merck & Co. Inc. during the 2011 PODD program. For the 2012 program agenda, please click here.
-
July 3, 2012
-
Keynotes & Leadership Announced for Global Clinical Trials 3rd Annual Event
New York - The Conference Forum has announced that the 3rd Annual Executing Global Clinical Trial’s event will take place on September 13-14 at the Fairmont Copley Square Hotel in Boston, MA. “The trend to globalization creates opportunities and challenges for clinical trial management. To be successful, we must focus on quality, ethics, fair market value, [...]
-
July 2, 2012
-
A Peak at GCT 2011
A Presentation on Corporate Social Responsibility, Applied Research Networks & Clinical Research Enterprise. This Presentation was delivered by Linda Strause, PhD of Vical Inc. and Matt Whalen, PhD of Impact LLC. during the 2011 GCT program. For the 2012 program agenda, please visit here.
-
June 4, 2012
-
A Peak at DPharm 2011: Private Public Partnerships Model: The Parkinson’s Progression Markers Initiative (PPMI): The Development of a Public-Private Partnership to Tackle Critical Research Hurdles This Presentation was delivered by Sohini Chowdhury, VP of Research Partnerships for the Michael J. Fox Foundation for Parkinsons Research during the 2011 DPharm program. For the 2012 program [...]
-
June 1, 2012
-
New Speaker & Agenda Announcements
We have added two exciting new items to our upcoming 3rd Annual Executing Global Clinical Trials event 2012! How to Do Clinical Trials in Europe: Clarifying Confusion, Changes & Updates An update on the clinical trial approval process in Europe How to get the correct scientific advice David R. Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare [...]
-
May 23, 2012
-
Yo Adrian! – The Disruptive Innovation Event Was A Knockout
Life Science Leaders Chief Editor, Rob Wright, was an attendee at DPharm 2011. Here are this thoughts on the conference. Philadelphia has a history of being the place where dreams become reality. Home to the signing of the U.S. Declaration of Independence and fictional boxing legend Rocky Balboa, Philly can now lay claim to yet [...]
-
May 23, 2012
-
DPharm 2011 Co Chair Blog
DPharm 2011 Co Chair Blog Our Co-Chair, Puneet Sapra, Director, World Wide Business Development & Innovation at Pfizer writes a blog about his thoughts from our September 2011 program: Last year, I had the pleasure of working with a distinguished and experienced team to curate the DPharm conference in Philadelphia in September — a TED-style [...]
-
May 1, 2012
-
2012 Dates Announced!
2nd Annual PODD- Partnership Opportunities in Drug Delivery October 1-2, 2012 Boston Park Plaza Hotel,Boston, MA For more information click here.
-
May 1, 2012
-
PODD 2011 Pictures
Pictures from our PODD 2011 Event, Omni Parker House Hotel, Boston, MA. For more information on our upcoming 2012 event, click here. Or join our LinkedIN group here. Click here to view these pictures larger
-
May 1, 2012
-
GCT 2011 Photos
Click here to view these pictures larger Pictures from our 2011 Executing Global Clinical Trials event, Philadelphia Loews Hotel. Philadelphia, PA. For more information on our 2012 event click here. Or to join our Linked IN group click here.
-
April 20, 2012
-
2012 Dates Announced!
3rd Annual Executing Global Clinical Trials Conference September 13-14, 2012 Fairmont Copley Square Hotel, Boston, MA For more information click here.
-
March 29, 2012
-
2012 & 2013 Dates Announced!
2nd Annual Disruptive Innovations to Advance Clinical Trials for Pharma, Biologics & Devices September 13th & 14th 2012 Fairmont Copley Plaza, Boston, MA 3rd Annual Executing Global Clinical Trials September 13th & 14th 2012 Fairmont Copley Plaza, Boston, MA 2nd Annual PODD; Partnership Opportunities in Drug Delivery October 1st & 2nd 2012 Boston Park Plaza [...]
-
March 29, 2012
-
2nd Annual Executing Global Clinical Trials and DPharm, Disruptive Innovation to Advance Clinical Trials for Pharma, Biologics & Devices Slideshow
The 2nd Annual Executing Global Clinical Trials Conference was co located with our DPharm; Disruptive Innovations to Advance Clinical Trials for Pharma, Biologics & Devices in September 2011 in the Philadelphia Loews Hotel, PA. 2nd Annual Executing Global Clinical Trials This strategic level event is focused on how to execute global trials to produce higher [...]
-
March 27, 2012
-
R&D Leadership Summit 2012
The Times Are A Changin’ In Drug Development R&D March 27, 2012 By Rob Wright, Chief Editor, Life Science Leader magazine This year’s R&D Leadership Summit took place March 19 to 20 in Aventura, FL. Organized by The Conference Forum and sponsored by RPS, the focus was on driving innovation, change, and performance of drug [...]
-
March 1, 2012
-
New Paradigms to Fund and Move Drug Development 2012
The New Paradigms to Fund and Advance Drug Development was held in January 10-12, 2012. Attended by all levels of Biotech CEOs, R&D leaders and the Investment community, the conference delivered information on alternative sources of funding, non-traditional partnering strategies and innovative approaches to drug approval for the successful commercialization of new therapies. For more [...]
-
February 1, 2012
-
Partnership Opportunities in Drug Delivery 2011 slideshow
The Conference Forum presented PODD, Partnership Opportunities in Drug Delivery, in October 2011 in Boston, MA. PODD was designed with two purposes: 1. To present a strategic level event for pharma and biotech business development and external licensing professionals with a thorough overview of the latest drug delivery technologies available along with an update on [...]
-
January 31, 2012
-
DPharm 2011 Co Chair Blog
Our Co-Chair, Puneet Sapra, Director, World Wide Business Development & Innovation at Pfizer writes a blog about his thoughts from our September 2011 program: Last year, I had the pleasure of working with a distinguished and experienced team to curate the DPharm conference in Philadelphia in September — a TED-style event showcasing innovations and leading [...]